Influenza Diagnostics Market Report Expects the Market Value of USD 1216.8 MN BY 2026
Posted On May 25, 2020
The Global Influenza Diagnostics Market by the year 2026 is expected to show a revenue growth of USD 1216.8 MN along with a CAGR of 8% between 2020 and 2026. The estimated revenue for the market was USD 710 MN in the year 2019 as stated in the report published by Value Market Research.The economies across the globe are investing in several programs and initiatives to combat the growing influenza outbreaks, thus acting as the driving parameter for the influenza diagnostics market. Moreover, the mounting amount of R&D, technological advancements in diagnostic tests, and soaring demands for influenza diagnosis are expected to boost the market in the future. However, the increasing prices of kits and reagents may serve as an obstacle.
Influenza commonly known as flu is a viral infection that attacks the respiratory system of humans. There exist three types of influenza viruses that can target humans, type A, type B, and type C. The symptoms range from the mild common cold-like symptoms to chronic conditions (asthma, neurodevelopmental disease, and even death). Children who are younger than 12 months and adults 65 years or over are more prone to get seasonal influenza. The influenza virus holds the potential to cause seasonal epidemics with high degrees of illness and mortality. Influenza diagnostics consists of several tests, traditional diagnostics tests (RIDT, Viral Culture, DFA Test, and Serological Assay), molecular diagnostic assay (RT-PCR, NASBA Test, LAMP, and SAMBA) conducted for the diagnosis of this infection. The application of these diagnostics is restricted to hospitals, research labs, and point of care clinics.
The detailed research study"Global Influenza Diagnostics Market Report By Test Type (RIDT, RT-PCR, Cell Culture And Others), End-Use (Hospital, POCT And Laboratories) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026" assists in understanding the market dynamics with qualitative as well as quantitative data.The contents of the report talks about historic data along with throwing light on the future opportunities of the influenza diagnostics market.
By test typethe influenza diagnostics market is segmented into RIDT, RT-PCR, cell culture and others. On the basis of end-use the influenza diagnostics market is segmented into hospital, POCT and laboratories.
The research study is broadly segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. The revenue and/ volume data distribution is covered in detail in the report.
The Report Segments Global Influenza Diagnostics Market -
By Test Type
- Cell Culture
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Players Profiled In the Report:
3M Health Care, Alere, Becton, Dickinson and Company (BD), Meridian Bioscience, Inc., Quidel Corporation, Roche Diagnostics Corporation, SA Scientific, Sekisui Diagnostics and Thermo Fisher Scientific, Inc. among others.
Download the FREE SAMPLE of Global Influenza Diagnostics Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]